HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John Papatriantafyllou Selected Research

John Papatriantafyllou Research Topics

Disease

3Dementia (Dementias)
05/2022 - 01/2021
2Cognitive Dysfunction
01/2021 - 11/2018
2Alzheimer Disease (Alzheimer's Disease)
01/2021 - 01/2021
1Neurodegenerative Diseases (Neurodegenerative Disease)
12/2023
1Agnosia (Visual Agnosia)
05/2022
1Frontotemporal Dementia (Semantic Dementia)
01/2021
1Feeding and Eating Disorders (Eating Disorder)
01/2021
1Pathologic Processes
11/2018
1Neuroinflammatory Diseases
11/2018
1Neurocognitive Disorders (Clerambault Syndrome)
01/2015
1Proteostasis Deficiencies
04/2010
1CADASIL
06/2007

Drug/Important Bio-Agent (IBA)

2Technetium Tc 99m Exametazime (Ceretec)FDA Link
05/2022 - 01/2021
1SolutionsIBA
12/2023
1Apolipoprotein E4IBA
01/2021
1RadiopharmaceuticalsIBA
11/2018
1Biomarkers (Surrogate Marker)IBA
11/2018
1Amyloid beta-PeptidesIBA
11/2018
1tau Proteins (tau Protein)IBA
11/2018
1DNA-Binding Proteins (DNA Binding Protein)IBA
04/2010
1Codon (Codons)IBA
06/2007
1Glycine (Aminoacetic Acid)FDA LinkGeneric
06/2007
1Cysteine (L-Cysteine)FDA Link
06/2007

Therapy/Procedure

1Institutionalization (Institutionalized Persons)
01/2022
1Cognitive Training
01/2015